CD25 targeting with the afucosylated human IgG1 antibody RG6292 eliminates regulatory T cells and CD25+ blasts in acute myeloid leukemia

BACKGROUND: Acute Myeloid leukemia is a heterogeneous disease that requires novel targeted treatment options tailored to the patients’ specific microenvironment and blast phenotype. METHODS: We characterized bone marrow and/or blood samples of 37 AML patients and healthy donors by high dimensional f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pousse, Laurène, Korfi, Koorosh, Medeiros, Bruno C., Berrera, Marco, Kumpesa, Nadine, Eckmann, Jan, Hutter, Idil Karakoc, Griesser, Vera, Karanikas, Vaios, Klein, Christian, Amann, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185852/
https://www.ncbi.nlm.nih.gov/pubmed/37205201
http://dx.doi.org/10.3389/fonc.2023.1150149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185852/
https://www.ncbi.nlm.nih.gov/pubmed/37205201
http://dx.doi.org/10.3389/fonc.2023.1150149

Ejemplares similares